Better cervical cancer prevention in Kenya and Malawi
Official title: Advancing Cancer Control for Health and Value (ACCHV)
Funded at New York University · NIH-11412300 · Data updated 2026-11-12
This project gathers local and national data to find ways to increase use of HPV vaccination, screening, and other prevention tools for women in Kenya and Malawi.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $75,830 |
| NIH project number | 3R37CA272664-02S1 |
| Project ID | NIH-11412300 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants include women and girls in Kenya or Malawi eligible for HPV vaccination or cervical screening, as well as health workers, caregivers, and community leaders who help deliver prevention services.
✕Less likely to help
People seeking immediate cancer treatment or those living outside Kenya and Malawi are unlikely to receive direct benefit from this prevention-focused project.
What this research studies
The team will collect interviews, surveys, and existing health records in Kenya and Malawi to understand how cervical cancer prevention programs work at community and national levels. They will combine qualitative and quantitative data to build multi-level statistical models that highlight factors linked to better prevention coverage. The researchers will run agent-based computer simulations to test which program changes could increase population-wide vaccination, screening, and follow-up. The project is led by New York University with experienced local partners in both countries.
Why it matters
Potential benefit: If successful, the findings could guide policies and programs that increase vaccination and screening and reduce cervical cancer cases in high-burden settings.
How similar studies have gone: Smaller, single-country projects have shown that targeted vaccination and screening programs can improve prevention, but this is the first large multi-country effort using multi-level and agent-based modeling together.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Moucheraud, Corrina — New York University
- Study coordinator: Moucheraud, Corrina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.